The results were shown at the British Association for Surgery of the Knee meeting in Norwich, UK.
The results presented include the following:
• A study found that in a population of 89 patients and 106 knees treated, no patients required blood transfusions and mean preoperative range of motion was regained within an average of four months.
• A study found that in a population of 63 patients treated with iTotal, 100 percent achieved alignment within ± 2 of the neutral mechanical axis.
• Finally, a study found that use of iTotal significantly improves tibial fit when compared to off-the-shelf total knee replacement implants.
ConforMIS is a medical device company focusing on patient-specific orthopedic implants.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
